[
    [
        {
            "time": "2021-04-30",
            "original_text": "华大基因：和玉高林与高林同创持股比例降至5%以下",
            "features": {
                "keywords": [
                    "华大基因",
                    "和玉高林",
                    "高林同创",
                    "持股比例",
                    "减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因：和玉高林与高林同创持股比例降至5%以下",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "华大基因(300676.SZ)股东深圳和玉高林等合计持股比例降至4.9999%",
            "features": {
                "keywords": [
                    "华大基因",
                    "深圳和玉高林",
                    "持股比例",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)股东深圳和玉高林等合计持股比例降至4.9999%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "华大基因：和玉高林和高林同创减持1734万股，不再是持股5%以上股东 减持股份",
            "features": {
                "keywords": [
                    "华大基因",
                    "和玉高林",
                    "高林同创",
                    "减持",
                    "持股5%以上股东"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因：和玉高林和高林同创减持1734万股，不再是持股5%以上股东 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "深圳百亿富商汪建，“喜提”第二家上市公司",
            "features": {
                "keywords": [
                    "汪建",
                    "华大基因",
                    "上市公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "深圳百亿富商汪建，“喜提”第二家上市公司",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "顶流基金最新动向曝光：张坤看多苏泊尔 高瓴旗下私募新进伊利股份、华大基因、安图生物",
            "features": {
                "keywords": [
                    "张坤",
                    "高瓴",
                    "华大基因",
                    "安图生物",
                    "伊利股份",
                    "苏泊尔",
                    "顶流基金"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "顶流基金最新动向曝光：张坤看多苏泊尔 高瓴旗下私募新进伊利股份、华大基因、安图生物",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-30",
            "original_text": "上市公司战“疫”成绩单亮相，停摆行业有望显著改善",
            "features": {
                "keywords": [
                    "上市公司",
                    "战疫",
                    "停摆行业",
                    "改善"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市公司战“疫”成绩单亮相，停摆行业有望显著改善",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]